Morning Brief

Markets eye Powell at Jackson Hole as retail earnings and Novo Nordisk rally

Share this episode
Anyone with this link can open it.
Share Link
Start at 0:00

This episode isn’t summarized yet

Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.

Show notes

Stock futures hover near record highs ahead of Fed Chair Powell’s final Jackson Hole speech, with investors betting on a September rate cut. Retail earnings from Walmart (WMT), Target (TGT), and Lowe’s (LOW) are in focus, while Novo Nordisk (NVO) surges on expanded drug approval. Soho House (MCG) also announces a $2.7B go-private deal.

Takeaways:

Powell’s last Jackson Hole speech could set the stage for a September rate cut

Markets remain resilient with tech and Q2 earnings fueling record highs

Walmart, Target, and Lowe’s headline a big week for retail earnings

Novo Nordisk gains FDA approval for Wegovy in liver disease, boosting stock

Soho House to go private in $2.7B deal with Ashton Kutcher joining the board

Yahoo Finance's flagship show, Morning Brief, is your go-to source for smarter investing and market moves.

Thoughts? Questions? Fan mail? Please email us at [email protected].
Learn more about your ad choices. Visit megaphone.fm/adchoices

Couldn't load the audio. A blocker may be stopping the show's tracking links. Open the file